ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.
äŒæ¥ã³ãŒãICUI
äŒç€ŸåICU Medical Inc
äžå Žæ¥Mar 31, 1992
æé«çµå¶è²¬ä»»è
ãCEOãJain (Vivek)
åŸæ¥å¡æ°15000
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Mar 31
æ¬ç€Ÿæåšå°951 Calle Amanecer
éœåžSAN CLEMENTE
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·92673-6212
é»è©±çªå·19493662183
ãŠã§ããµã€ãhttps://www.icumed.com/
äŒæ¥ã³ãŒãICUI
äžå Žæ¥Mar 31, 1992
æé«çµå¶è²¬ä»»è
ãCEOãJain (Vivek)